A quercetin and resveratrol blend’s obesity-reducing effects are linked to its anti-inflammatory properties; it decreases adipokine secretion, activates AMPKα1/SIRT1 signaling, and thus may reduce HFD-induced obesity and inflammation [181]. Here, PRKAA1 is linked to obesity due to melanocortin 4 receptor deficiency.